259 related articles for article (PubMed ID: 17846106)
1. Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.
de Steenwinkel JE; van Vianen W; Ten Kate MT; Verbrugh HA; van Agtmael MA; Schiffelers RM; Bakker-Woudenberg IA
J Antimicrob Chemother; 2007 Nov; 60(5):1064-73. PubMed ID: 17846106
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
Tomioka H; Sato K; Saito H
Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
[TBL] [Abstract][Full Text] [Related]
3. [Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection].
Payen MC; De Wit S; Clumeck N
Rev Mal Respir; 1997 Dec; 14 Suppl 5():S142-51. PubMed ID: 9496599
[TBL] [Abstract][Full Text] [Related]
4. TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
Cynamon MH; Klemens SP; Swenson CE
J Antimicrob Chemother; 1992 Jun; 29(6):693-9. PubMed ID: 1387133
[TBL] [Abstract][Full Text] [Related]
5. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
6. IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice.
Doherty TM; Sher A
J Immunol; 1998 Jun; 160(11):5428-35. PubMed ID: 9605144
[TBL] [Abstract][Full Text] [Related]
7. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.
Jenkins PA; Campbell IA; Banks J; Gelder CM; Prescott RJ; Smith AP
Thorax; 2008 Jul; 63(7):627-34. PubMed ID: 18250184
[TBL] [Abstract][Full Text] [Related]
8. [Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
Tanaka E
Kekkaku; 1996 Sep; 71(9):547-9. PubMed ID: 8999140
[No Abstract] [Full Text] [Related]
9. [In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice].
Akaki T; Sato K; Shimizu T; Tomioka H; Kawahara S
Kekkaku; 1997 Aug; 72(8):491-7. PubMed ID: 9293712
[TBL] [Abstract][Full Text] [Related]
10. [Expectation of new antituberculous drugs and targeting therapy for treatment of mycobacterial infections].
Tomioka H
Kekkaku; 1993 Nov; 68(11):723-30. PubMed ID: 8264129
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients].
Shirasaka T
Kekkaku; 2007 Nov; 82(11):845-8. PubMed ID: 18078110
[TBL] [Abstract][Full Text] [Related]
12. Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential.
Ahmad Z; Pandey R; Sharma S; Khuller GK
Indian J Chest Dis Allied Sci; 2006; 48(3):171-6. PubMed ID: 18610673
[TBL] [Abstract][Full Text] [Related]
13. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study.
Kobashi Y; Matsushima T
Respiration; 2007; 74(4):394-400. PubMed ID: 16954651
[TBL] [Abstract][Full Text] [Related]
14. Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice.
Kuze F
Am Rev Respir Dis; 1984 Mar; 129(3):453-9. PubMed ID: 6703503
[TBL] [Abstract][Full Text] [Related]
15. [A drug delivery system and biological response modifiers for the treatment of mycobacterial infection].
Koga H; Miyazaki Y; Kohno S; Hara K
Kekkaku; 1994 Feb; 69(2):113-8. PubMed ID: 8126987
[TBL] [Abstract][Full Text] [Related]
16. Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection.
Bermudez LE; Kolonoski P; Young LS; Inderlied CB
Antimicrob Agents Chemother; 1994 Aug; 38(8):1844-8. PubMed ID: 7986018
[TBL] [Abstract][Full Text] [Related]
17. Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series.
Davis KK; Kao PN; Jacobs SS; Ruoss SJ
BMC Pulm Med; 2007 Feb; 7():2. PubMed ID: 17319962
[TBL] [Abstract][Full Text] [Related]
18. Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome.
Baron EJ; Young LS
Diagn Microbiol Infect Dis; 1986 Sep; 5(3):215-20. PubMed ID: 3757474
[TBL] [Abstract][Full Text] [Related]
19. Progress report: prophylaxis and therapy for MAC.
Currier J
AIDS Clin Care; 1996 Jun; 8(6):45-8. PubMed ID: 11363599
[TBL] [Abstract][Full Text] [Related]
20. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
